This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Oncology
Oncology
Bevacizumab can pose thromboembolism risk
UK launch for dexrazoxane
Positive data for azacitidine in MDS
Renal cancer care: raising the bar
Benny and 2-CdA
Avastin boosts Genentech revenues
Roche joins RNAi gene pool
No gain from clodronate
Genmab regains lymphoma drug rights
Cost-effective formularies for the management of bone metastases secondary to breast cancer
Lapatinib: an oral dual ErbB1 and ErbB2 inhibitor for the treatment of breast cancer
Adding capecitabine “prolongs cancer survival”
« Previous
1
…
133
134
135
136
137
…
151
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: